JNJ P&L Curve
Johnson & Johnson (JNJ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $554.67B, listed on NYSE, employing roughly 138,100 people, carrying a beta of 0.26 to the broader market. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. Led by Joaquin Duato, public since 1943-01-02.
A profit/loss curve charts the theoretical gain or loss of an options position across a range of underlying prices. It helps traders visualize risk, identify breakeven points, and compare strategies before committing capital.
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Market Cap
- $554.67B
- Employees
- 138.1K
- IPO Date
- 1943-01-02
- CEO
- Joaquin Duato
- Beta
- 0.26
At the current $227.34 spot price with 21.5% ATM implied volatility and 28 days to the front expiration, an at-the-money long straddle carries an approximate combined premium near $10.85, producing breakevens at roughly $216.49 and $238.19. Market-implied 1-standard-deviation range extends from $213.31 to $241.37, which sets the relevant P&L evaluation window for most near-term strategies. Payoff diagrams should be rebuilt from the live options chain; the preceding values are illustrative and assume a single at-the-money straddle for reference.
Frequently asked JNJ pl curve questions
- What does a JNJ ATM straddle cost today?
- Using current JNJ pricing (21.5% ATM IV, 28-day front expiration, $227.34 spot), an at-the-money long straddle (long call + long put at the same strike) carries an approximate combined premium near $10.85 per spread. Breakevens land at roughly $238.19 on the upside and $216.49 on the downside. The estimate uses the Brenner-Subrahmanyam approximation for at-the-money options under Black-Scholes.
- How do I read an options P&L curve?
- An options P&L curve plots theoretical position value at expiration (or at any chosen evaluation date) against the underlying price. The X-axis is the underlying price scenario, the Y-axis is position dollar P&L. The shape of the curve tells you the strategy's directional sensitivity, breakeven points, maximum profit and loss levels, and where time decay or volatility shifts will be most impactful. Multi-leg structures combine the curves of the individual legs to produce composite payoff diagrams.
- What's the difference between a P&L curve and a payoff diagram?
- Strictly: a payoff diagram shows option value at expiration (no time premium left), while a P&L curve typically shows position value at any evaluation date (with remaining time premium). The expiration payoff diagram has kinks at the strikes; the early P&L curve is smooth. For directional-vega trades, the early P&L curve also responds to IV shifts that the expiration payoff diagram does not capture - which is why options traders often look at both views.
- Why are illustrative JNJ P&L numbers approximate?
- The numbers above use Black-Scholes assumptions (lognormal returns, constant volatility, no early exercise, no dividends). Real-world option prices reflect skew, term structure, jump risk, and (for US-style options) early exercise premium. Use the live options chain for actual quoted bid/ask prices when sizing trades; the values here illustrate magnitude only.